News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
648,555 Results
Type
Article (34188)
Company Profile (694)
Press Release (613673)
Section
Business (198504)
Career Advice (2115)
Deals (36554)
Drug Delivery (98)
Drug Development (78160)
Employer Resources (162)
FDA (15322)
Job Trends (14649)
News (334849)
Policy (29211)
Tag
Academia (1397)
Alliances (47640)
Alzheimer's disease (1219)
Approvals (15275)
Artificial intelligence (153)
Bankruptcy (367)
Best Places to Work (10842)
Biotechnology (475)
Breast cancer (180)
Cancer (1415)
Cardiovascular disease (116)
Career advice (1745)
Cell therapy (314)
Clinical research (63149)
Collaboration (572)
Compensation (305)
COVID-19 (2172)
C-suite (145)
Data (1424)
Diabetes (180)
Diagnostics (6173)
Earnings (81917)
Employer resources (140)
Events (107885)
Executive appointments (492)
FDA (16055)
Funding (501)
Gene therapy (208)
GLP-1 (641)
Government (2888)
Healthcare (15905)
Infectious disease (2264)
Inflammatory bowel disease (116)
Interviews (420)
IPO (17100)
Job creations (4247)
Job search strategy (1454)
Layoffs (488)
Legal (7343)
Lung cancer (206)
Manufacturing (231)
Medical device (13406)
Medtech (13411)
Mergers & acquisitions (19714)
Metabolic disorders (486)
Neuroscience (1597)
NextGen: Class of 2025 (5989)
Non-profit (1938)
Northern California (1870)
Obesity (280)
Opinion (232)
Patents (134)
People (56298)
Pharmaceutical (142)
Phase I (19829)
Phase II (28163)
Phase III (20907)
Pipeline (620)
Postmarket research (1979)
Preclinical (8042)
Radiopharmaceuticals (253)
Rare diseases (286)
Real estate (5800)
Regulatory (20428)
Research institute (1384)
Resumes & cover letters (330)
Southern California (1596)
Startups (3882)
United States (16679)
Vaccines (551)
Weight loss (204)
Date
Today (109)
Last 7 days (379)
Last 30 days (1959)
Last 365 days (35208)
2025 (1751)
2024 (35710)
2023 (40397)
2022 (50857)
2021 (54255)
2020 (51173)
2019 (42186)
2018 (32196)
2017 (32691)
2016 (31000)
2015 (36542)
2014 (29348)
2013 (24271)
2012 (25884)
2011 (26112)
2010 (23924)
Location
Africa (677)
Arizona (137)
Asia (41956)
Australia (6700)
California (4333)
Canada (1543)
China (369)
Colorado (190)
Connecticut (213)
Europe (87775)
Florida (563)
Georgia (143)
Illinois (350)
Indiana (250)
Maryland (599)
Massachusetts (3447)
Michigan (195)
Minnesota (322)
New Jersey (1199)
New York (1191)
North Carolina (875)
Northern California (1870)
Ohio (141)
Pennsylvania (976)
South America (1073)
Southern California (1596)
Texas (620)
Utah (121)
Washington State (446)
648,555 Results for "sumitomo chemical company ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical
December 2, 2024
·
6 min read
BioMidwest
Sumitomo Chemical and Valent BioSciences Announce Divestiture of Pace International and Future Collaboration with AgroFresh Solutions in the Postharvest Solutions Space
Sumitomo Chemical Co., Ltd. and Valent BioSciences LLC announced that Pace International LLC and its operations overseas will become part of AgroFresh Solutions, Inc., a well-established leader in the postharvest solutions space.
March 27, 2024
·
5 min read
Business
Ginkgo Bioworks and Sumitomo Chemical Announce Expanded Partnership To Develop Functional Chemicals with Synthetic Biology
Sumitomo Chemical Co., Ltd and Ginkgo Bioworks today announced a new program to develop functional chemicals with synthetic biology and expand upon the companies’ existing biomanufacturing partnership.
July 18, 2023
·
6 min read
Press Releases
Sumitomo Pharma America Announces U.S. FDA Approval of GEMTESA® (vibegron) for Men with Overactive Bladder Symptoms Receiving Pharmacological Therapy for Benign Prostatic Hyperplasia
December 23, 2024
·
8 min read
Business
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., and Sumitomo Mitsui Banking Corporation announced that the three companies signed a master agreement on April 22, 2024, to establish a joint venture company.
April 22, 2024
·
5 min read
Press Releases
Sumitomo Pharma America Presents New Data on Nuvisertib and Enzomenib at the 2024 American Society of Hematology Annual Meeting
December 9, 2024
·
9 min read
Genetown
Conagen and Sumitomo Chemical jointly develop a new era of renewable carbon materials
Conagen, the bioplatform innovator and biomanufacturer, and Sumitomo Chemical, Japan’s leading chemical company, have announced to jointly develop p-hydroxystyrene and its polymer, poly p-hydroxystyrene, using a combination of biosynthesis, chemosynthesis, and polymerization.
August 1, 2023
·
3 min read
Genetown
Sumitomo Pharma Presents New Clinical Data on DSP-5336 at the European Hematology Association 2024 Congress
Sumitomo Pharma America, Inc. (SMPA) today announced the oral presentation of data from the ongoing Phase 1/2 first-in-human study of DSP-5336 in patients with relapsed or refractory acute leukemia at the European Hematology Association (EHA) 2024 Hybrid Congress.
June 14, 2024
·
7 min read
Business
RevolKa Ltd.: Announcement of Milestone Achievement in the Collaborative Research with Sumitomo Pharma Co., Ltd.
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform is pleased to announce the successful completion of the collaborative drug discovery project with Sumitomo Pharma Co., Ltd. for rare diseases within the contractually agreed time frame.
June 23, 2023
·
3 min read
Drug Development
Sumitomo Pharma Presents Urology and Oncology Data at AUA 2024 Annual Meeting
Sumitomo Pharma America, Inc., (SMPA) today announced the presentation of data from URO-901-3005, a Phase 3 randomized, double-blind, parallel-group, fixed-dose study evaluating the efficacy, safety, and tolerability of vibegron.
May 7, 2024
·
8 min read
1 of 64,856
Next
